ABSTRAKLesi Dieulafoy's merupakan salah satu penyebab perdarahan saluran cerna yang cukup jarang terjadi namun menjadi salah satu penyebab yang penting. Patogenesis penyakit ini berkembang dari awal penemuannya sampai sekarang. Dari studi terakhir dikatakan bahwa etiologi kelainan ini bermacam-macam, mulai dari genetik sampai pengaruh usia. Kelainan ukuran dan bentuk arteriol diketahui menjadi patogenesis utama kelainan ini. Endoskopi menjadi teknik diagnosis utama dengan efektivitas mencapai lebih dari 90%. Namun, pada beberapa keadaan kelainan ini sulit ditemukan melalui teknik endoskopi. Tata laksana utama adalah dengan teknik hemostasis via endoskopi. Teknik tersebut saat ini sudah berkembang dan bervariasi, mulai dari termal koagulasi, mekanik, sampai injeksi epinefrin. Seiring perkembangan teknologi kedokteran, prognosis penyakit ini saat ini cukup baik. ABSTRACTDieulafoy's lesion is a rare cause of upper gastrointestinal bleeding but become an important etiology. Pathogenesis of the disease evolved from earlier of its invention till now. It has been stated in recent study that the etiology of this disease is vary, from age to genetic. Size and arteriol configuration abnormality has been known as the main pathogenesis of the disease. Endoscopic procedure become the primary diagnostic tool, which effectiveness reached more than 90%. However, in some situation, it's difficult to find the abnormality by endoscopic procedure. Hemostatic procedure via endoscopy is the main therapy of Dieulafoy's lesion, which has been progressed from thermal coagulation, mechanical procedure, and epinephrine injection. The development of medical technology has made the better prognosis of the disease.
Objective: Every year, millions of Muslims from around the world gather in Saudi Arabia to perform Hajj. Before leaving for pilgrimage, Indonesian pilgrims go through various health examinations in Regional Primary Health Center (Pusat Kesehatan Masyarakat/ Puskesmas). Since there was no existing research on Asthma Control Test (ACT) assessment for pilgrims with bronchial asthma to predict asthma exacerbations during Hajj pilgrimage period, this cohort study was conducted to fill this gap.Methods: Pilgrims who suffered from asthma were recruited in Daerah Khusus Ibukota (DKI) Jakarta Province region in 2018. The degree classification of asthma in the ACT group was determined as uncontrolled, partially controlled, and fully controlled. ACT scores were calculated in Puskesmas and embarkation. Observation of asthma exacerbations in pilgrims while performing Hajj was performed by doctors. Data were analyzed with SPSS for Windows.Results: A total of 68 participants were included (46 female [67.6%]; 45 aged <60 years [66.2%]). At embarkation, the asthma classification based on the ACT was as follows: 36 (52.9%) and 13 (19.1%) pilgrims had partially controlled and uncontrolled asthma, and 17 (47.2%) and 8 (61.5%) of each group experienced exacerbation, respectively, with p = 0.006 for the ACT values at embarkation. The area under the curve value was 0.717 (95% CI; 0.596-0.838).Conclusion: There was increased asthma exacerbation incidence in the uncontrolled and partially controlled ACT groups at embarkation compared to the fully controlled ACT group. The ACT score was able to predict the occurrence of acute asthma exacerbation during Hajj period.International Journal of Human and Health Sciences Vol. 04 No. 02 April’20 Page : 128-135
Haji Ahmad Sanusi (Ulama dan Pejuang)
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.